LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Boragen was formed to develop synthetic fungicides based on a group of boron-containing compounds. In 2022, the company split into three separate companies, 5Metis, Borah and Reactive Biosciences.
Boragen
Research Triangle Park, NC
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.